Nebulised heparin as a treatment for lung diseases: formulation challenges and pulmonary drug delivery strategies
Crossref DOI link: https://doi.org/10.1007/s00408-026-00905-y
Published Online: 2026-07-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miranda, Margarida
Brown, Marc
van Haren, Frank M. P.
Brown, Beth
Page, Clive P.
Text and Data Mining valid from 2026-07-01
Version of Record valid from 2026-07-01
Article History
Received: 28 April 2026
Accepted: 8 June 2026
First Online: 1 July 2026
Declarations
:
: The authors declare no competing interest.